Chakraborty Shamik, Bodhinayake Imithri, Chiluwal Amrit, Langer David J, Ruggieri Rosamaria, Symons Marc, Boockvar John A
Brain Tumor Biotech Center, Feinstein Institute for Medical Research, Hofstra Northwell School of Medicine, Manhasset, NY, USA.
Department of Neurological Surgery, Hofstra Northwell School of Medicine, Manhasset, NY, USA.
J Neurooncol. 2016 May;128(1):175-182. doi: 10.1007/s11060-016-2087-z. Epub 2016 Feb 20.
The Brain Tumor Biotech Center at the Feinstein Institute for Medical Research, in collaboration with Voices Against Brain Cancer hosted The Brain Tumor Biotech Summit at in New York City in June 2015. The focus was once again on fostering collaboration between neuro-oncologist, neurosurgeons, scientists, leaders from biotechnology and pharmaceutical industries, and members of the financial community. The summit highlighted the recent advances in the treatment of brain tumor, and specifically focused on targeting of stem cells and EGFR, use of prophage and immunostimulatory vaccines, retroviral vectors for drug delivery, biologic prodrug, Cesium brachytherapy, and use of electric field to disrupt tumor cell proliferation. This article summarizes the current progress in brain tumor research as presented at 2015 The Brain Tumor Biotech Summit.
2015年6月，费因斯坦医学研究所的脑肿瘤生物技术中心与“抗击脑癌之声”合作，在纽约市举办了脑肿瘤生物技术峰会。会议重点再次放在促进神经肿瘤学家、神经外科医生、科学家、生物技术和制药行业领袖以及金融界成员之间的合作上。峰会突出了脑肿瘤治疗方面的最新进展，特别聚焦于干细胞和表皮生长因子受体（EGFR）的靶向治疗、噬菌体和免疫刺激疫苗的应用、用于药物递送的逆转录病毒载体、生物前体药物、铯近距离治疗以及利用电场干扰肿瘤细胞增殖。本文总结了在2015年脑肿瘤生物技术峰会上展示的脑肿瘤研究的当前进展。
